Form D · Pharmaceuticals

Beam Therapeutics Inc.

Cambridge, MA · CIK 0001745999

Offering snapshot reported Mar 26, 2019 · SEC filing

Reported sold
$83.6M
Offering amount: $83.6M
Investors reported
21
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 9, 2018
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$41.8M$83.6MAug 9, 2018: $44,999,981.00Aug 9, 2018Mar 26, 2019: $83,573,967.00Mar 26, 2019

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$44,999,981 → $83,573,967
  • Reported investors20 → 21

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 26, 2019Amendment$83,573,967$38,573,986vs Aug 9, 201821SEC filing
Mar 26, 2019Initial$135,000,002No comparison27SEC filing
Aug 9, 2018Initial$44,999,981No comparison20SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-318897

Source: Form D, filed Mar 26, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kristina Burow Director
John Evans Director, Executive
Mark Fishman Director
Carole Ho Director
Stephen Knight Director
Robert Nelsen Director
Robert Nelson Director
Michael Yi Director
Feng Zhang Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
26 Landsdowne Street
Cambridge, MA, 02139